CardioNet (BEAT) Updates Mobile Cardio Telemetry Reimbursement Info

November 2, 2009 7:44 AM EST

CardioNet, Inc. (NASDAQ: BEAT) announced today that the Centers for Medicare and Medicaid Services has not established a national pricing reimbursement rate for mobile cardiovascular telemetry (CPT Code 93229) in the Medicare final rule for the physician fee schedule for calendar year 2010. Reimbursement for mobile cardiovascular telemetry will continue to be carrier priced by Highmark Medicare Services.

Randy Thurman, Chairman, President and Chief Executive Officer of CardioNet, stated, "We are extremely disappointed that CMS has not established a national reimbursement rate for mobile cardiovascular telemetry and that it will continue to be regionally priced by HMS. CardioNet and other industry providers have now serviced nearly 400,000 patients nationally, of which a significant portion were Medicare patients. Since the unexpected announcement by Highmark on July 10, 2009, we provided CMS and HMS with substantial data that we believe justified a significantly higher national reimbursement rate and we will continue to work with CMS on a national price for 2011."

CMS also updated the national technical fees for event and Holter monitoring for the calendar year 2010. Event monitoring (CPT Code 93271) and Holter monitoring (CPT Code 93226) reimbursement will be reduced approximately 7% and 16%, respectively, compared to the 2009 rates.


Related Categories

Corporate News

Stocks Mentioned

BEAT 4.99

-0.04 -0.80%
Volume: 143,079
Track BEAT


Add Your Comment